Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle

Biomarkers

Volumn 13, Issue 2, 2008, Pages 160-183

  Browne, Richard W ^a   Bloom, Michael S ^c   Schisterman, Enrique F ^c   Hovey, Kathy ^b   Trevisan, Maurizio ^b   Wu, Chengqing ^c   Liu, Aiyi ^c   Wactawski Wende, Jean ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Antioxidants; Biological variation; Menstrual cycle; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; BIOLOGICAL MARKER; DELTA TOCOPHEROL; GAMMA TOCOPHEROL; LINOLEIC ACID; LIPID PEROXIDE; LYCOPENE; RETINOL; SCAVENGER; TRACE ELEMENT; VITAMIN; XANTHOPHYLL;

ADULT; ANALYSIS OF VARIANCE; ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; ARTICLE; BIOASSAY; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BLOOD SAMPLING; FEMALE; GENETIC VARIABILITY; HUMAN; LABORATORY TEST; LIPID PEROXIDATION; MENSTRUAL CYCLE; OXIDATIVE STRESS; QUALITY CONTROL; WOMEN'S HEALTH;

ADOLESCENT; ADULT; ASCORBIC ACID; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MENSTRUAL CYCLE; OXIDATIVE STRESS; QUALITY CONTROL; SUPEROXIDE DISMUTASE;

EID: 39149145505     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500701775563     Document Type: Article

References (75)

1. Agar, J. and Durham, H. (2003) Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 4, pp. 232-242.
2. Agarwal, A., Gupta, S. and Sharma, RK. (2005) Role of oxidative stress in female reproduction. Reproductive Biology & Endocrinology, 3, p. 28.
3. Andersen, HR, Nielsen, JB, Nielsen, F. and Grandjean, P. (1997) Antioxidative enzyme activities in human erythrocytes. Clinical Chemistry, 43, pp. 562-568.
4. Armstrong, D. and Browne, R. (1994) The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Free Radicals in Diagnostic Medicine, Advances in Experimental Medicine & Biology, 366, pp. 43-58. Plenum Press, New York
5. Basu, S. (2003) Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology, 189, pp. 113-127.
6. Browne, RW and Armstrong, D. (1998) Simultaneous determination of serum retinol, tocopherols and carotenoids by high pressure liquid chromatography. Methods in Molecular Biology, 108, pp. 269-275.
7. Browne, RW and Armstrong, D. (2000) HPLC analysis of lipid derived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma. Clinical Chemistry, 46, pp. 829-836.
8. Browne, RW, Koury, ST, Marion, SM, Wilding, G., Muti, P. and Trevisan, M. (2007) Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay. Clinical Chemistry, 53, pp. 310-317.
9. Chait, A. (1994) Low-density lipoprotein oxidation and the pathogenesis of atherosclerosis. Western Journal of Medicine, 160, pp. 183-184.
10. Chalmers, AH and McWhinney, BC. (1986) Two spectrophotometric methods compared for measuring low concentrations of ascorbate in plasma and urine. Clinical Chemistry, 32, pp. 1412-1413.
11. Collins, AR, Cadet, J., Moller, L., Poulsen, HE and Vina, J. (2004) Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?. Archives of Biochemistry & Biophysics, 423, pp. 57-65.
12. Cotlove, E., Harris, EK and Williams, GZ. (1970) Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications. Clinical Chemistry, 16, pp. 1028-1032.
13. Dandona, P. (2002) Endothelium, inflammation, and diabetes. Current Diabetes Reports, 2, pp. 311-315.
14. Davies, MJ, Fu, S., Wang, H. and Dean, RT. (1999) Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radical Biology & Medicine, 27, pp. 1151-1163.
15. Dawson, TM and Dawson, VL. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science, 302, pp. 819-822.
16. De Zwart, LL, Meerman, JHN, Commandeur, JNM and Vermeulen, NPE. (1999) Biomarkers of free radical damage: Applications in experimental animals and in humans. Free Radical Biology & Medicine, 26, pp. 202-226.
17. Forman, MR, Beecher, GR, Muesing, R., Lanza, E., Olson, B., Campbell, WS, McAdam, P., Raymond, E., Schulman, JD and Graubard, BI. (1996) The fluctuation of plasma carotenoid concentrations by phase of the menstrual cycle: A controlled diet study. American Journal of Clinical Nutrition, 64, pp. 559-565.
18. Fraser, CG. (1992) Biological variation in clinical chemistry. an update: Collected data, 1988-1991. Archives of Pathology & Laboratory Medicine, 116, pp. 916-923.
19. Fraser, CG and Harris, EK. (1989) Generation and application of data on biological variation in clinical chemistry. Critical Reviews in Clinical & Laboratory Science, 27, pp. 409-437.
20. Fraser, CG, Hyltoft, PP, Libeer, JC and Ricos, C. (1997) Proposals for setting generally applicable quality goals solely based on biology. Annals of Clinical Biochemistry, 34, pp. 8-12.
21. Fraser, CG and Petersen, P. Hyltoft (1999) Analytical performance characteristics should be judged against objective quality specifications. Clinical Chemistry, 45, pp. 321-323.
22. Guemouri, L., Artur, Y., Herbeth, B., Jeandel, C., Cuny, G. and Siest, G. (1991) Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clinical Chemistry, 37, pp. 1932-1937.
23. Ha, EJ and Smith, AM. (2003) Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle. Journal of the American College of Nutrition, 22, pp. 43-51.
24. Helmersson, J. and Basu, S. (2001) F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans. Prostaglandins, Leukotrienes. and Essential Fatty Acids, 65, pp. 99-102.
25. Hensley, K., Williamson, KS and Floyd, RA. (2000) Measurement of 3-nitrotyrosine and 5-nitro-γ-tocopherol by high-performance liquid chromatography with electrochemical detection. Free Radical Biology & Medicine, 28, pp. 520-528.
26. Petersen, P Hyltoft, Fraser, CG, Jorgensen, L., Brandslund, I., Stahl, M. and Gowans, E. (2002) Combination of analytical quality specifications based on biological within- and between-subject variation. Annals of Clinical Biochemistry, 39, pp. 543-550.
27. Jenkins, C., Wilson, R., Roberts, J., Miller, H., McKillop, JH and Walker, JJ. (2000) Antioxidants: Their role in pregnancy and miscarriage. Antioxidants & Redox Signaling, 2, pp. 623-628.
28. Kadiiska, MB, Gladen, BC, Baird, DD, Graham, LB, Parker, CE and Ames, BN (2005) Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radical Biology & Medicine, 38, pp. 711-718.
29. Kadiiska, MB, Gladen, BC, Baird, DD, Germolec, D., Graham, LB and Parker, CE (2005) Biomarkers of oxidative stress study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radical Biology & Medicine, 38, pp. 698-710.
30. Kadiiska, MB, Gladen, BC, Baird, DD, Dikalova, AE, Sohal, RS and Hatch, GE (2000) Biomarkers of oxidative stress study: Are plasma antioxidants markers of CCl(4) poisoning?. Free Radical Biology & Medicine, 28, pp. 838-845.
31. Kato, I., Ren, J., Heilbrun, LK and Djuric, Z. (2006) Intra- and inter-individual variability in measurements of biomarkers for oxidative damage in vivo: Nutrition and Breast Health Study. Biomarkers, 11, pp. 143-152.
32. Kim, YJ, Hong, YC, Lee, KH, Park, HJ, Park, EA and Moon, HS (2005) Oxidative stress in pregnant women and birth weight reduction. Reproductive Toxicology, 19, pp. 487-492.
33. Kruidenier, L., Kuiper, I., Lamers, CB and Verspaget, HW. (2003) Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. Journal of Pathology, 201, pp. 28-36.
34. Lachin, JM. (2004) The role of measurement reliability in clinical trials. Clinical Trials, 1, pp. 553-566.
35. Lanza, E., Forman, MR, Johnson, EJ, Muesing, RA, Graubard, BI and Beecher, GR. (1998) alpha-Tocopherol concentrations in plasma but not in lipoproteins fluctuate during the menstrual cycle in healthy premenopausal women. Journal of Nutrition, 128, pp. 1150-1155.
36. Littell, RC, Henry, PR and Ammerman, CB. (1998) Statistical analysis of repeated measures data using SAS procedures. Journal of Animal Science, 76, pp. 1216-1231.
37. Liu, J., Yeo, HC, Doniger, SJ and Ames, BN. (1997) Assay of aldehydes from lipid peroxidation: Gas chromatography-mass spectrometry compared to thiobarbituric acid. Analytical Biochemistry, 245, pp. 161-166.
38. Maas, JW, Groothuis, PG, Dunselman, GA, de Goeij, AF and Boudier, HA Struyker (2001) Endometrial angiogenesis throughout the human menstrual cycle. Human Reproduction, 16, pp. 1557-1561.
39. Maes, M., Weeckx, S., Wauters, A., Neels, H., Scharpe, S. and Verkerk, R. (1996) Biological variability in serum vitamin E concentrations: relation to serum lipids. Clinical Chemistry, 42, pp. 1824-1831.
40. Margolis, SA and Duewer, DL. (1996) Measurement of ascorbic acid in human plasma and serum: Stability, intralaboratory repeatability, and interlaboratory reproducibility. Clinical Chemistry, 42, pp. 1257-1262.
41. Massafra, C., De Felice, C., Gioia, D. and Buonocore, G. (1998) Variations in erythrocyte antioxidant glutathione peroxidase activity during the menstrual cycle. Clinical Endocrinology, 49, pp. 63-67.
42. Massafra, C., Gioia, D., De Felice, C., Picciolini, E., De Leo, V. and Bonifazi, M. (2000) Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle. Journal of Endocrinology, 167, pp. 447-452.
43. Mathur, S., Devaraj, S. and Jialal, I. (2002) Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease. Current Opinion in Nephrology and Hypertension, 11, pp. 141-147.
44. Matsubasa, T., Uchino, T., Karashima, S., Kondo, Y., Maruyama, K. and Tanimura, M. (2002) Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. Free Radical Research, 36, pp. 189-193.
45. Morrow, JD, Awad, JA, Boss, HJ, Blair, IA and Roberts, LJ. (1992) Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proceedings of the National Academy of Sciences, 89, pp. 10721-10725.
46. Multhaup, G. and Masters, CL. (1999) Metal binding and radical generation of proteins in human neurological diseases and aging. Metal Ions in Biological Systems, 36, pp. 365-387.
47. Murphy, JM, Browne, RW, Hill, L., Bolelli, GF, Abagnato, C. and Berrino, F. (2000) Effects of transportation and delay in processing on the stability of nutritional and metabolic biomarkers. Nutrition & Cancer, 37, pp. 155-160.
48. Murphy, AA, Santanam, N. and Parthasarathy, S. (1998) Endometriosis: A disease of oxidative stress?. Seminars in Reproductive Endocrinology, 16, pp. 263-273.
49. Murray, AA, Molinek, MD, Baker, SJ, Kojima, FN, Smith, MF and Hillier, SG (2001) Role of ascorbic acid in promoting follicle integrity and survival in intact mouse ovarian follicles in vitro. Reproduction, 121, pp. 89-96.
50. Nielsen, F., Mikkelsen, BB, Nielsen, JB, Andersen, HR and Grandjean, P. (1997) Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clinical Chemistry, 43, pp. 1209-1214.
51. Olinski, R., Gackowski, D., Foksinski, M., Rozalski, R., Roszkowski, K. and Jaruga, P. (2002) Oxidative DNA damage: Assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radical Biology & Medicine, 33, pp. 192-200.
52. Palan, PR, Magneson, AT, Castillo, M., Dunne, J. and Mikhail, MS. (2006) Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants. American Journal of Obstetrics & Gynecology, 194, p. e35.
53. Paredi, P., Kharitonov, SA and Barnes, PJ. (2002) Analysis of expired air for oxidation products. American Journal of Respiratory and Critical Care Medicine, 166, pp. S31-S37.
54. Pippenger, CE, Browne, RW and Armstrong, D. (1998) Regulatory antioxidant enzymes. Methods in Molecular Biology, 108, pp. 299-313.
55. Pratico, D., Rokach, J., Lawson, J. and Fitzgerald, GA. (2004) F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chemistry & Physics Lipids, 128, pp. 165-171.
56. Pryor, WA. (1999) Oxidative stress status: OSS, BOSS and "Wild Bill" Donovan. Free Radical Biology & Medicine, 27, pp. 1135-1136.
57. Pryor, WA and Godber, SS. (1991) Noninvasive measures of oxidative stress status in humans. Free Radical Biology & Medicine, 10, pp. 177-184.
58. Rayman, MP. (2000) The importance of selenium to human health. Lancet, 356, pp. 233-241.
59. Reimer, RA, Debert, CT, House, JL and Poulin, MJ. (2005) Dietary and metabolic differences in pre versus postmenopausal women taking or not taking hormone replacement therapy. Physiology & Behavior, 84, pp. 303-312.
60. Ricos, C., Garcia-Lariol, J-V, Alvarez, V., Caval, F., Domenechl, M., Hernandez, A. et al. (2004) Biological variation database, and quality specifications for imprecision, bias and total error (desirable and minimum): The 2004 update. Westgard QC
61. Rock, CL, Demitrack, MA, Rosenwald, EN and Brown, MB. (1995) Carotenoids and menstrual cycle phase in young women. Cancer Epidemiology. Biomarkers & Prevention, 4, pp. 283-288.
62. Samborskaia, E. and Ferdman, T. (1966) Mechanism of abortion induced by ascorbic acid. Biulletin Eksperimentalnoi Biologii I Meditsiny, 62, pp. 96-98.
63. Schisterman, EF, Vexler, A., Whitcomb, BW and Liu, A. (2006) The limitations due to exposure detection limits for regression models. American Journal of Epidemiology, 163, pp. 374-383.
64. Schisterman, E., Whitcomb, B., Louis, G. and Louis, T. (2005) Lipid adjustment in the analysis of environmental contaminants and human health risks. Environmental Health Perspectives, 113, pp. 853-857.
65. Sebastian-Gimbaro, MA. (1997) Intra- and inter-individual biological variability data bank. European Journal of Clinical Chemistry and Clinical Biochemistry, 35, pp. 845-852.
66. Serviddio, G., Loverro, G., Vicino, M., Prigigallo, F., Grattagliano, I. and Altomare, E. (2002) Modulation of endometrial redox balance during the menstrual cycle: Relation with sex hormones. The Journal of Clinical Endocrinology and Metabolism, 87, pp. 2843-2848.
67. Soory, M. (2002) Hormone mediation of immune responses in the progression of diabetes, rheumatoid arthritis and periodontal diseases. Current Drug Targets. Immune. Endocrine and Metabolic Disorders, 2, pp. 13-25.
68. Spector, A. (2000) Review: Oxidative stress and disease. Journal of Ocular Pharmacology and Therapeutics, 16, pp. 193-201.
69. Spiteller, P. and Spiteller, G. (1997) 9-Hydroxy-10,12-octadecadieneoic acid (9HODE) and 13- Hydroxy-9,11-octadecadieneoic acid (13HODE): excellent markers for lipid peroxidation. Chemistry & Physics Lipids, 89, pp. 131-139.
70. Talwar, DK, Azharuddin, MK, Williamson, C., Teoh, YP, McMillan, DC and O'Reilly, D. (2005) Biological variation of vitamins in blood of healthy individuals. Clinical Chemistry, 51, pp. 2145-2150.
71. Tangney, C., Brownie, C. and Wu, SM. (1991) Impact of menstrual periodicity on serum lipid levels and estimates of dietary intakes. Journal of the American College of Nutrition., 10, pp. 107-113.
72. Terada, LS. (2006) Specificity in reactive oxidant signaling: Think globally, act locally. Journal of Cell Biology, 174, pp. 615-623.
73. Westgard, J., Carey, R. and Wold, S. (1974) Criteria for judging precision and accuracy in method development and evaluation. Clinical Chemistry, 20, pp. 825-833.
74. Westgard, J., Groth, T. and Aronsson, T. (1977) Combined Shewhart-cusum control chart for improved quality control in clinical chemistry. Clinical Chemistry, 23, pp. 1881-1887.
75. Xu, D., Ong, C. and Shen, H. (2001) The associations between concentration of selenium in semen and sperm parameters as well as oxidative DNA damage in human sperm. Chinese Journal of Preventive Medicine, 35, pp. 394-396.